Manufacturer of Controlled Substances; Notice of Registration, 73369 [E7-25047]
Download as PDF
<![CDATA[
73369
Federal Register / Vol. 72, No. 247 / Thursday, December 27, 2007 / Notices
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Cody
Laboratories to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Cody
Laboratories to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–25041 Filed 12–26–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on PROD1PC66 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated September 24, 2007
and published in the Federal Register
on October 2, 2007, (72 FR 56102), ISP
Freetown Fine Chemicals, 238 South
Main Street, Assonet, Massachusetts
02702, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Phenylacetone (8501), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
Phenylacetone to manufacture
Amphetamine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
ISP Freetown Fine Chemicals to import
the basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated ISP
Freetown Fine Chemicals to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
VerDate Aug<31>2005
18:00 Dec 26, 2007
Jkt 214001
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–25046 Filed 12–26–07; 8:45 am]
the basic classes of controlled
substances listed.
Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–25047 Filed 12–26–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Registration
DEPARTMENT OF JUSTICE
By Notice dated September 21, 2007,
and published in the Federal Register
on September 27, 2007, (72 FR 54931),
Varian, Inc., Lake Forest, 25200
Commercentre Drive, Lake Forest,
California 92630–8810, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated September 12, 2007,
and published in the Federal Register
on September 19, 2007 (72 FR 53606),
Research Triangle Institute, Kenneth H.
Davis Jr., Hermann Building, P.O. Box
12194, East Institute Drive, Research
Triangle, North Carolina 27709, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
I
II
The Institute will manufacture small
quantities of cocaine and marihuana
derivatives for use by their customers in
analytical kits, reagents, and reference
standards as directed by NIDA.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Research Triangle Institute to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Research Triangle Institute
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
Frm 00060
Phencyclidine (7471) ......
1–
Piperidinocyclohexanecarbonitrile (8603).
Benzoylecgonine (9180)
Schedule
II
II
II
Schedule
Marihuana (7360) ...........
Cocaine (9041) ...............
PO 00000
Drug
Fmt 4703
Sfmt 4703
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Varian, Inc. to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Varian,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 72, Number 247 (Thursday, December 27, 2007)]
[Notices]
[Page 73369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-25047]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated September 12, 2007, and published in the Federal
Register on September 19, 2007 (72 FR 53606), Research Triangle
Institute, Kenneth H. Davis Jr., Hermann Building, P.O. Box 12194, East
Institute Drive, Research Triangle, North Carolina 27709, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
----------------------------------------------------------------------------------------------------------------
Drug Schedule
----------------------------------------------------------------------------------------------------------------
Marihuana (7360)............................... I
Cocaine (9041)................................. II
----------------------------------------------------------------------------------------------------------------
The Institute will manufacture small quantities of cocaine and
marihuana derivatives for use by their customers in analytical kits,
reagents, and reference standards as directed by NIDA.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Research Triangle Institute to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Research Triangle Institute to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-25047 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P
